PMID: 44912Dec 1, 1979

Adverse reactions to medication on a coronary care unit

Postgraduate Medical Journal
R H Falk

Abstract

In a prospective survey of treatment on a coronary care unit 23.6% of patients who received medication had one or more side effects. In several cases these were severe enough to cause marked deterioration of the patient's clinical status. Whilst antiarrhythmic therapy is an integral part of modern coronary care its potential hazards should be recognized, particularly in the elderly patient.

Citations

Mar 1, 1978·The American Journal of Cardiology·R P Lasser, H N Chang
Apr 1, 1978·Intensive Care Medicine·N Buchanan, R D Cane
Mar 1, 1969·British Medical Journal·N Hurwitz, O L Wade
Jan 16, 1967·JAMA : the Journal of the American Medical Association·B LownG W Thorn

Related Concepts

Anti-Arrhythmia Agents
Antiarrhythmic [EPC]
Myocardial Infarction
Mapluxin
Cardiac Depressants
Atropen
Heart
Lidocaine Monohydrochloride, Monohydrate
Cardiac Arrhythmia
Adrenergic beta-Antagonists

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.